| Date |
Time |
Source |
Heading |
|---|
| 4/19/2024 | 16:05 | EDGAR2 | Form ARS - Annual Report to Security Holders |
| 4/19/2024 | 16:04 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
| 4/19/2024 | 16:02 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 3/19/2024 | 17:10 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 3/19/2024 | 17:02 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 3/19/2024 | 07:09 | EDGAR2 | Form 8-K - Current report |
| 11/20/2023 | 18:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/20/2023 | 18:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/06/2023 | 16:30 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
| 10/30/2023 | 16:15 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
| 10/27/2023 | 17:17 | EDGAR2 | Form 8-K - Current report |
| 10/27/2023 | 16:02 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
| 10/26/2023 | 17:34 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 10/26/2023 | 17:00 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 10/26/2023 | 16:46 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 10/20/2023 | 21:23 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 10/17/2023 | 17:47 | GLOBE | Talaris Therapeutics Announces Stockholder Approval of.. |
| 10/10/2023 | 16:32 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 10/10/2023 | 16:30 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
| 10/06/2023 | 20:01 | DJN | Stocks to Watch: Shift Technologies, Talaris Therapeutics,.. |
| 10/06/2023 | 17:30 | EDGAR2 | Form 8-K - Current report |
| 10/06/2023 | 17:27 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 10/06/2023 | 17:26 | EDGAR2 | Form 8-K - Current report |
| 10/06/2023 | 17:09 | GLOBE | Talaris Therapeutics Declares Special Dividend In Connection.. |
| 10/04/2023 | 08:30 | GLOBE | New York Blood Center Enterprises Acquires Commercial-Scale.. |
| 9/26/2023 | 08:24 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 9/26/2023 | 08:21 | EDGAR2 | Form 8-K - Current report |
| 9/15/2023 | 06:31 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 9/13/2023 | 16:28 | EDGAR2 | Form S-4/A - Registration of securities, business.. |
| 9/13/2023 | 09:14 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 9/13/2023 | 09:13 | EDGAR2 | Form 8-K - Current report |
| 9/11/2023 | 16:47 | EDGAR2 | Form S-4/A - Registration of securities, business.. |
| 8/28/2023 | 07:38 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 8/25/2023 | 16:34 | EDGAR2 | Form S-4/A - Registration of securities, business.. |
| 8/14/2023 | 07:53 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 6/22/2023 | 07:30 | GLOBE | Talaris Therapeutics and Tourmaline Bio Announce Merger.. |
| 5/26/2023 | 07:00 | GLOBE | Talaris Therapeutics Announces Leadership Transition |
News
Market Data
Register to chat with like-minded investors on our interactive forums.
